Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L39 pseudogene 15 (RPL39P15) is a pseudogene in the human genome related to the functional ribosomal protein L39 gene (RPL39)[4]. Pseudogenes like RPL39P15 are genomic sequences that resemble known genes but typically lack the ability to encode functional proteins due to mutations or truncations. RPL39P15 is specifically one of several processed pseudogenes derived from the parental RPL39 gene, which encodes a component of the ribosomal large 60S subunit essential for protein synthesis[1][4]. There is no evidence supporting any biological activity, direct disease association, or therapeutic relevance for RPL39P15[1][4]. RPL39P15 is therefore not considered a therapeutic target, nor does it have known roles as a biomarker or drug interaction partner. Its sole distinction is as a genomic sequence homologous to the functional ribosomal protein gene, with no established function or interaction profile in health or disease contexts[4].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L39 pseudogene 15 (RPL39P15).